Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion type Assertion NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_head.
- NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion description "[Their levels fell further with increasing tumour's stage and were higher in tumours from patients who remained disease free compared with those who developed local recurrence or distant metastasis or died from breast cancer.TRF2 showed a trend similar to that of TANK2 and POT1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_provenance.
- NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion evidence source_evidence_literature NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_provenance.
- NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion SIO_000772 17616810 NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_provenance.
- NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion wasDerivedFrom befree-20140225 NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_provenance.
- NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_assertion wasGeneratedBy ECO_0000203 NP566919.RARx0T-27MVRDapfH3RXj4O7tpIJK5ZfPhe5n9m_4lqpI130_provenance.